Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy

Podobne zapisy

• CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
  od: Miri, Seyed Mohammad, i wsp.
  Wydane: (2020)
• Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
  od: Seyed Mohammad Miri, i wsp.
  Wydane: (2020-10-01)
• CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy
  od: Salas-Mckee, January, i wsp.
  Wydane: (2019)
• CRISPR-Cas systems: ushering in the new genome editing era
  od: Perez Rojo, Fernando, i wsp.
  Wydane: (2018)
• Precision gene editing: The power of CRISPR-Cas in modern genetics
  od: Jeong H. Joo, i wsp.
  Wydane: (2025-12-01)